Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 2,156 | 7,718 | 1,692 | 658 | 463 |
| Gross Profit | 2,156 | 7,718 | 1,692 | 658 | 463 |
| Operating Expenses | 15,808 | 13,414 | 12,776 | 11,593 | 10,434 |
| Operating Income | -13,652 | -5,696 | -11,084 | -10,935 | -9,971 |
| Other Income | 502 | 624 | 485 | 472 | 15 |
| Pre-tax Income | -13,150 | -5,072 | -10,599 | -10,463 | -9,956 |
| Net Income Continuous | -13,150 | -5,072 | -10,599 | -10,463 | -9,956 |
| Net Income | $-13,150 | $-5,072 | $-10,599 | $-10,463 | $-9,956 |
| EPS Basic Total Ops | -0.74 | -0.29 | -0.57 | -0.60 | -0.69 |
| EPS Basic Continuous Ops | -0.74 | -0.29 | -0.57 | -0.60 | -0.69 |
| EPS Diluted Total Ops | -0.74 | -0.29 | -0.57 | -0.60 | -0.69 |
| EPS Diluted Continuous Ops | -0.74 | -0.29 | -0.57 | -0.60 | -0.69 |
| EBITDA(a) | $-13,464 | $-5,512 | $-10,945 | $-10,854 | $-9,877 |